MENU
+Compare
GOSS
Stock ticker: NASDAQ
AS OF
Jul 21, 12:33 PM (EDT)
Price
$1.78
Change
+$0.08 (+4.71%)
Capitalization
386.41M

GOSS Gossamer Bio Forecast, Technical & Fundamental Analysis

Gossamer Bio Inc is a clinical-stage biopharmaceutical company... Show more

GOSS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for GOSS with price predictions
Jul 18, 2025

GOSS's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for GOSS turned positive on July 11, 2025. Looking at past instances where GOSS's MACD turned positive, the stock continued to rise in of 45 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on July 10, 2025. You may want to consider a long position or call options on GOSS as a result. In of 81 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where GOSS advanced for three days, in of 260 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 185 cases where GOSS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The RSI Indicator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 5 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where GOSS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

GOSS broke above its upper Bollinger Band on July 16, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. GOSS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (8.091) is normal, around the industry mean (18.143). P/E Ratio (0.000) is within average values for comparable stocks, (58.647). GOSS's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.460). Dividend Yield (0.000) settles around the average of (0.041) among similar stocks. P/S Ratio (3.090) is also within normal values, averaging (270.975).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GOSS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
GOSS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

GOSS is expected to report earnings to rise 12.81% to -18 cents per share on August 12

Gossamer Bio GOSS Stock Earnings Reports
Q2'25
Est.
$-0.18
Q1'25
Beat
by $0.03
Q4'24
Beat
by $0.02
Q3'24
Beat
by $0.01
Q2'24
Missed
by $0.29
The last earnings report on May 15 showed earnings per share of -15 cents, beating the estimate of -18 cents. With 601.82K shares outstanding, the current market capitalization sits at 386.41M.
A.I. Advisor
published General Information

General Information

a company, which engages in discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
3013 Science Park Road
Phone
+1 858 684-1300
Employees
135
Web
https://www.gossamerbio.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MPNGY34.081.64
+5.06%
MEITUAN
GCHEF7.89N/A
N/A
Grupo Comercial Chedrui SAB de CV
BRRDF17.40N/A
N/A
Borregaard ASA
ENMHF0.03N/A
N/A
ENM Holdings, Ltd.
CLSH0.04N/A
N/A
CLS Holdings USA, Inc.

GOSS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, GOSS has been loosely correlated with ABEO. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if GOSS jumps, then ABEO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GOSS
1D Price
Change %
GOSS100%
-0.58%
ABEO - GOSS
41%
Loosely correlated
-0.60%
SLDB - GOSS
38%
Loosely correlated
+10.36%
XNCR - GOSS
34%
Loosely correlated
-1.10%
CRBU - GOSS
34%
Loosely correlated
+12.02%
ATXS - GOSS
34%
Loosely correlated
-5.69%
More